Athira Pharma to Pay $4 Million Over Alleged Research Misconduct

Dow Jones

06 Jan

By Dean Seal

Athira Pharma has agreed to pay over $4 million to settle the government's claims that it failed to report alleged research misconduct to federal agencies.

The Department of Justice said Monday that between 2016 and June 2021, Athira failed to report allegations that former Chief Executive Leen Kawas falsified scientific images in her doctoral dissertation, as well as published research papers referenced in grant applications submitted to the National Institutes of Health.

The NIH funded a grant to the company in 2019 based on an application that included manipulated scientific images, the DOJ said.

Athira has agreed to resolve allegations that it violated the False Claims Act. Of the total payment, about $200,000 will go to Andrew Mallon, who brought claims on behalf of the U.S. government as a whistleblower.

A representative for Athira didn't immediately respond to a request for comment.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

January 06, 2025 17:58 ET (22:58 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2501299365"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2501299365\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2501299365?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-07 06:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501299365","market":"sh","top_or_hot":-1,"title":"Athira Pharma to Pay $4 Million Over Alleged Research Misconduct","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Dean Seal \n</p>\n<p>\n  Athira Pharma has agreed to pay over $4 million to settle the government's claims that it failed to report alleged research misconduct to federal agencies. \n</p>\n<p>\n  The Department of Justice said Monday that between 2016 and June 2021, Athira failed to report allegations that former Chief Executive Leen Kawas falsified scientific images in her doctoral dissertation, as well as published research papers referenced in grant applications submitted to the National Institutes of Health. \n</p>\n<p>\n  The NIH funded a grant to the company in 2019 based on an application that included manipulated scientific images, the DOJ said. \n</p>\n<p>\n  Athira has agreed to resolve allegations that it violated the False Claims Act. Of the total payment, about $200,000 will go to Andrew Mallon, who brought claims on behalf of the U.S. government as a whistleblower. \n</p>\n<p>\n  A representative for Athira didn't immediately respond to a request for comment. \n</p>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 06, 2025 17:58 ET (22:58 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Athira Pharma to Pay $4 Million Over Alleged Research Misconduct</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAthira Pharma to Pay $4 Million Over Alleged Research Misconduct\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-07 06:58</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Dean Seal \n</p>\n<p>\n  Athira Pharma has agreed to pay over $4 million to settle the government's claims that it failed to report alleged research misconduct to federal agencies. \n</p>\n<p>\n  The Department of Justice said Monday that between 2016 and June 2021, Athira failed to report allegations that former Chief Executive Leen Kawas falsified scientific images in her doctoral dissertation, as well as published research papers referenced in grant applications submitted to the National Institutes of Health. \n</p>\n<p>\n  The NIH funded a grant to the company in 2019 based on an application that included manipulated scientific images, the DOJ said. \n</p>\n<p>\n  Athira has agreed to resolve allegations that it violated the False Claims Act. Of the total payment, about $200,000 will go to Andrew Mallon, who brought claims on behalf of the U.S. government as a whistleblower. \n</p>\n<p>\n  A representative for Athira didn't immediately respond to a request for comment. \n</p>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 06, 2025 17:58 ET (22:58 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2501299365","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501299365","pubTimestamp":1736204280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Athira Pharma has agreed to pay over $4 million to settle the government's claims that it failed to report alleged research misconduct to federal agencies.The Department of Justice said Monday that between 2016 and June 2021, Athira failed to report allegations that former Chief Executive Leen Kawas falsified scientific images in her doctoral dissertation, as well as published research papers referenced in grant applications submitted to the National Institutes of Health.The NIH funded a grant to the company in 2019 based on an application that included manipulated scientific images, the DOJ said.Athira has agreed to resolve allegations that it violated the False Claims Act. Of the total payment, about $200,000 will go to Andrew Mallon, who brought claims on behalf of the U.S. government as a whistleblower.A representative for Athira didn't immediately respond to a request for comment.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","ATHA":"Athira Pharma, Inc."},"translate_title":"Athira Pharma因涉嫌研究不当行为支付400万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATHA":1},"content_text":"By Dean Seal \n\n\n  Athira Pharma has agreed to pay over $4 million to settle the government's claims that it failed to report alleged research misconduct to federal agencies. \n\n\n  The Department of Justice said Monday that between 2016 and June 2021, Athira failed to report allegations that former Chief Executive Leen Kawas falsified scientific images in her doctoral dissertation, as well as published research papers referenced in grant applications submitted to the National Institutes of Health. \n\n\n  The NIH funded a grant to the company in 2019 based on an application that included manipulated scientific images, the DOJ said. \n\n\n  Athira has agreed to resolve allegations that it violated the False Claims Act. Of the total payment, about $200,000 will go to Andrew Mallon, who brought claims on behalf of the U.S. government as a whistleblower. \n\n\n  A representative for Athira didn't immediately respond to a request for comment. \n\n\n  Write to Dean Seal at dean.seal@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 06, 2025 17:58 ET (22:58 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."

Consult now
Download APP
Scan QR code to download the app.